The global wearable injectors market is projected to reach USD 11.5billion by 2026 from USD 7.2billion in 2021, at a CAGR of 9.9% during the forecast period. Growth in this market is mainly driven by factors such as the shift of healthcare delivery toward homecare due to COVID-19, advantages of wearable injectors in the administration of various drugs, the rising prevalence of chronic diseases (such as cancer, diabetes, and CVD), favorable reimbursement scenario in major markets, and technological advancements in injector devices. However, the preference for alternative drug delivery modes, high costs, and a poor reimbursement structure in developing countries are expected to limit the adoption of wearable injectors to a certain extent.
The on-body injectors segment holds the highest market share, by type, in thewearable injectors market, in the forecast period. By type, the global wearable injectors market is segmented into on-body injectors and off-body injectors.The on-body injectors segment accounted for the largest share in the forecast year.
The large share of this segment can be attributed to the patients ease to deliver a precise amount of drug to the body over a controlled period of time.
The spring based segment holds the highest market share, by technology, in the wearable injectors market, in the forecast period. Based on technology, the wearable injectors market is segmented into spring-based, motor-driven, rotary pump, expanding battery, and other technologies.The spring-based technology segment accounted for the largest share in the forecast period.
The large share of this segment can be attributed to the rising demand for adhesive patches, as these devices are user-friendly and enable patients to accurately deliver the required drug subcutaneously.
The diabetes segment holds the highest market share, by therapy, in the wearable injectors market, in the forecast period. Based on therapy, the wearable injectors market is segmented into immuno-oncology, diabetes, cardiovascular diseases, and other therapies (such as Parkinson’s disease, thalassemia, and primary immunodeficiency disorders).The diabetes segment accounted for the largest share in the forecast period.
The large share of this segment can be attributed to The high burden of diabetes across the globe, coupled with the growing availability of wearable injectors for the treatment of these diseases, is driving the growth of this market segment.
In wearable injectors market by end user segment, Hospitals and clinics holds the highest market share Based on end user, the wearable injectors market is segmented into hospitals and clinics and home healthcare settings.The hospitals and clinics segment accounted for a larger market share during the forecast period.
The large share of this segment can primarily be attributed to the rising preference for the self-administration of medication and the increasing need to curb healthcare costs. In addition, the growing demand for technologically developed drug delivery approaches, which lower the hospitalization rate and require minimal expertise, is expected to boost the growth of the home healthcare settings segment.
North America holds the largest share in thewearable injectors market, by region, in the forecast period The wearable injectors market in North America accounted for the largest market during the forecast period.The large share of North America in this market is to the rising prevalence of chronic and lifestyle-related diseases and the presence of advanced healthcare infrastructure in the region.
However, the Europe market is estimated to grow at the highest CAGR during the forecast period owing to factors such as the Increasing prevalence of chronic diseases, Government support for drug development in Germany, Rising focus on biosimilar innovation in the UK, Favorable reimbursement scenario for various treatment options in France.
A breakdown of the primary participants for the wearable injectors marketreferred to for this report is provided below: • By Company Type: Tier 1–55%, Tier 2–25%, and Tier 3–20% • By Designation: C-level–43%, Director Level–32%, and Others–25% • By Region: North America–38%, Europe–23%, Asia Pacific–29%,RoW- 10%
The prominent players in the wearable injectors market include Becton, Dickinson and Company(US), Ypsomed(Switzerland), Amgen(US), Subcuject(Denmark), Enable Injections(US), Medtronic Plc(Ireland), Insulet Corporation(US), United Therapeutics Corp (Us), CeQur SA(Switzerland), Sensile Medical(Switzerland), Steadymed Therapeutics (US), ATS Automation(Canada), West Pharmaceutical Services, Inc(US), Unilife Corporation(UK), Tandem Diabetes Care(US), Valeritas(US), Bühler Motor(Switzerland), Sonceboz(Switzerland), Noble(US), Elcam Drug Delivery Device(Israel), Bespak (UK), Stevanato Group(Italy), Sorrel Medical(Israel), Weibel CDS AG(Switzerland) and Neuma(US).
Research Coverage: The report analyzes the market for various wearable injectorsand their adoption pattern.It aims at estimating the market size and future growth potential of the global wearable injectors marketand different segments such astype, technology, therapy, end userand region.
The report also includes an in-depth competitive analysis of the key players in this market along with their company profiles, product& service offerings, and recent developments.
Reasons to Buy the Report The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would helpthemgarner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening theirmarket presence.
This report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the global wearable injectorsmarket • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities,and product or service launches in the global wearable injectorsmarket • Market Development: Comprehensive information on the lucrative emerging regionsbytype, technology, therapy, end user,and region • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in theglobal wearable injectors market. • Competitive Assessment: In-depth assessment of market shares, growth strategies, revenue analysis,and products& services of leading players in theglobal wearable injectors market.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Sep 2021
Major players in the protein expression market are Agilent Technologies, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., New England Biolabs and Promega Corporation. The global protein expression market is expected to grow from $2.01 billion in 2020 to $2.13 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth...
175 pages •
By The Business Research Company
• Sep 2021
Major players in the temperature management market are 3M Company, Becton, Dickinson and Company, Draegerwerk AG & Co.KGaA, Smiths Medical, Stryker Corporation, The 37company (The Surgical Company), Zoll Medical Corporation (A Subsidiary of Asahi Kasei Corporation), C. R. Bard, Mennen Medical, and Medtronic (Covidien). The global...
175 pages •
By The Business Research Company
• Aug 2021
Major players in the mobile imaging services market are Accurate Imaging Inc., Alliance HealthCare Services Inc., Axiom Mobile Imaging, Carestream Health, Center for Diagnostic Imaging Inc., Cobalt Health, DMS Health Technologies Inc., Front Range Mobile Imaging Inc., Imaging On Site Inc., InHealth Group Limited, Interim Diagnostic Imaging...
Taking care: Increasing chronic disease management is expected to drive industry revenue growth Abstract Home Care Providers in the US The Home Care Providers industry is among the fastest-growing healthcare industries in the United States. Home care saves patients billions of dollars every year by...
The pen needles market is expected to reach USD 2.2 Billion by 2026 from an estimated USD 1.3 Billion in 2021, at a CAGR of 11.2%. Growth in the market is largely driven by the growing prevalence of chronic diseases and the favorable reimbursement scenario in selected countries. On the other hand, the preference for alternative modes of drug...
The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of...
Home Infusion Therapy Market Size, Share & Trends Analysis Report By Product (Infusion Pumps, Needleless Connectors), By Application (Anti-infective, Chemotherapy), By Region, And Segment Forecasts, 2021 - 2028 Home Infusion Therapy Market Growth & Trends The global home infusion therapy market...
The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products. The global increase in the number of geriatrics population and obese people is likely to...
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.